Fig. 3From: Cost-utility analysis of palonosetron in the antiemetic regimen for cisplatin-containing highly emetogenic chemotherapy in JapanIncremental cost-effectiveness plane for probabilistic sensitivity analyses. WTP: Willingness-to-pay; JPY: Japanese yenBack to article page